Tag: pharmaceutical competition

7

Jun

Authorized Generics in Patent Litigation: Impact on Competition

Authorized Generics in Patent Litigation: Impact on Competition

Explore how authorized generics disrupt pharmaceutical competition. Learn about their impact on patent litigation, FTC regulations, and the Hatch-Waxman Act.

VIEW MORE
18

May

Generic Drug Shortages: Too Many Competitors or Not Enough Makers?

Generic Drug Shortages: Too Many Competitors or Not Enough Makers?

Explore the paradox of generic drug shortages: why increased competition leads to fragile supply chains. Learn about the economic pressures, regulatory hurdles, and the optimal number of manufacturers needed for stability.

VIEW MORE
29

Jan

Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs

Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs

Big pharma companies are using legal loopholes to block generic drugs from replacing brand-name medicines, costing patients billions. Learn how product hopping, REMS abuse, and withdrawal tactics undermine pharmacy substitution laws - and who’s fighting back.

VIEW MORE

Categories

Popular posts

Popular tags

Menu

© 2026. All rights reserved.